HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Permissions Request Permissions Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Roussos, C. Articles by Koutsoukou, A. Search for Related Content PubMed PubMed Citation Articles by Roussos, C. Articles by Koutsoukou, A.

Respiratory failure

Dept of Critical Care and Pulmonary Services, University of Athens Medical School, Evangelismos Hospital, Athens, Greece

CORRESPONDENCE: C. Roussos, Dept of Critical Care, Evangelismos Hospital, 45–47 Ipsilandou Street, GR-106 76, Athens, Greece. Fax: 30 2107216503. E-mail: croussos@cc.uoa.gr

Keywords: β-Endorphins, cytokines, hypercapnia, pump failure, respiratory muscles fatigue

Received: April 7, 2003
Accepted August 7, 2003

This study was supported by the Thorax Foundation, Athens, Greece.

Respiratory failure occurs due mainly either to lung failure resulting in hypoxaemia or pump failure resulting in alveolar hypoventilation and hypercapnia. Hypercapnic respiratory failure may be the result of mechanical defects, central nervous system depression, imbalance of energy demands and supplies and/or adaptation of central controllers.

Hypercapnic respiratory failure may occur either acutely, insidiously or acutely upon chronic carbon dioxide retention. In all these conditions, pathophysiologically, the common denominator is reduced alveolar ventilation for a given carbon dioxide production.

Acute hypercapnic respiratory failure is usually caused by defects in the central nervous system, impairment of neuromuscular transmission, mechanical defect of the ribcage and fatigue of the respiratory muscles.

The pathophysiological mechanisms responsible for chronic carbon dioxide retention are not yet clear. The most attractive hypothesis for this disorder is the theory of "natural wisdom". Patients facing a load have two options, either to push hard in order to maintain normal arterial carbon dioxide and oxygen tensions at the cost of eventually becoming fatigued and exhausted or to breathe at a lower minute ventilation, avoiding dyspnoea, fatigue and exhaustion but at the expense of reduced alveolar ventilation. Based on most recent work, the favoured hypothesis is that a threshold inspiratory load may exist, which, when exceeded, results in injury to the muscles and, consequently, an adaptive response is elicited to prevent and/or reduce this damage. This consists of cytokine production, which, in turn, modulates the respiratory controllers, either directly through the blood or probably the small afferents or via the hypothalamic-pituitary-adrenal axis. Modulation of the pattern of breathing, however, ultimately results in alveolar hypoventilation and carbon dioxide retention.

This article has been cited by other articles:

				M. L. Duiverman, J. B. Wempe, G. Bladder, H. A. M. Kerstjens, and P. J. Wijkstra Health-related quality of life in COPD patients with chronic respiratory failure Eur. Respir. J., August 1, 2008; 32(2): 379 - 386. [Abstract] [Full Text] [PDF]

				M. Decramer and C. Roussos Treatment of respiratory failure: introduction Eur. Respir. J., November 16, 2003; 22(47_suppl): 1s - 2s. [Full Text] [PDF]

				P.M.A. Calverley Respiratory failure in chronic obstructive pulmonary disease Eur. Respir. J., November 16, 2003; 22(47_suppl): 26s - 30s. [Abstract] [Full Text] [PDF]